Mesenchymal stem cell-based therapy for ischemic stroke

Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently approved treatments for ischemic stroke have narrow therapeutic windows, severely limiting the number of patients able to be treated. Mesenchymal stem cells represent a promising novel treatment for ischemic stroke. Numerous studies have demonstrated that mesenchymal stem cells functionally improve outcomes in rodent models of ischemic stroke. Recent studies have also shown that exosomes secreted by mesenchymal stem cells mediate much of this effect. In the present review, we summarize the current literature on the use of mesenchymal stem cells to treat ischemic stroke. Further studies investigating the mechanisms underlying mesenchymal stem cells tissue healing effects are warranted and would be of benefit to the field

Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas

We investigated the natural course of adrenal incidentalomas in 115 patients by means of a long-term endocrine and morphological (CT) follow-up protocol (median 4 year, range 1–7 year). At entry, we observed 61 subclinical hormonal alterations in 43 patients (mainly concerning the ACTH–cortisol axis), but confirmatory tests always excluded specific endocrine diseases. In all cases radiologic signs of benignity were present. Mean values of the hormones examined at last follow-up did not differ from those recorded at entry. However in individual patients several variations were observed. In particular, 57 endocrine alterations found in 43 patients (37.2%) were no longer confirmed at follow-up, while 35 new alterations in 31 patients (26.9%) appeared de novo. Only four alterations in three patients (2.6%) persisted. Confirmatory tests were always negative for specific endocrine diseases. No variation in mean mass size was found between values at entry (25.4±0.9 mm) and at follow-up (25.7±0.9 mm), although in 32 patients (27.8%) mass size actually increased, while in 24 patients (20.8%) it decreased. In no case were the variations in mass dimension associated with the appearance of radiological criteria of malignancy. Kaplan–Meier curves indicated that the cumulative risk for mass enlargement (65%) and for developing endocrine abnormalities (57%) over time was progressive up to 80 months and independent of haemodynamic and humoral basal characteristics. In conclusion, mass enlargement and the presence or occurrence over time of subclinical endocrine alterations are frequent and not correlated, can appear at any time, are not associated with any basal predictor and, finally, are not necessarily indicative of malignant transformation or of progression toward overt disease

Mesenchymal stem cell-based therapy for ischemic stroke

Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently approved treatments for ischemic stroke have narrow therapeutic windows, severely limiting the number of patients able to be treated. Mesenchymal stem cells represent a promising novel treatment for ischemic stroke. Numerous studies have demonstrated that mesenchymal stem cells functionally improve outcomes in rodent models of ischemic stroke. Recent studies have also shown that exosomes secreted by mesenchymal stem cells mediate much of this effect. In the present review, we summarize the current literature on the use of mesenchymal stem cells to treat ischemic stroke. Further studies investigating the mechanisms underlying mesenchymal stem cells tissue healing effects are warranted and would be of benefit to the field

From Grain to Floodplain: Evaluating heterogeneity of floodplain hydrostatigraphy using sedimentology, geophysics, and remote sensing

Stratigraphy is a fundamental component of floodplain heterogeneity and hydraulic conductivity and connectivity of alluvial aquifers, which affect hydrologic processes such as groundwater flow and hyporheic exchange. Watershed-scale hydrological models commonly simplify the sedimentology and stratigraphy of floodplains, neglecting natural floodplain heterogeneity and anisotropy. This study, conducted in the upper reach of the East River in the East River Basin, Colorado, USA, combines point-, meander-, and floodplain-scale data to determine key features of alluvial aquifers important for estimating hydrologic processes. We compare stratigraphy of two meanders with disparate geometries to explore floodplain heterogeneity and connectivity controls on flow and transport. Meander shape, orientation, and internal stratigraphy affected residence time estimates of laterally exchanged hyporheic water. Although the two meanders share a sediment source, vegetation, and climate, their divergent river migration histories resulted in contrasting meander hydrofacies. In turn, the extent and orientation of these elements controlled the effective hydraulic conductivity and, ultimately, estimates of groundwater transport and hyporheic residence times. Additionally, the meanders’ orientation relative to the valley gradient impacted the hydraulic gradient across the meanders—a key control of groundwater velocity. Lastly, we combine our field data with remotely sensed data and introduce a potential approach to estimate key hydrostratigraphic packages across floodplains. Prospective applications include contaminant transport studies, hyporheic models, and watershed models. © 2019 John Wiley & Sons, Ltd